NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hepion Pharmaceuticals Inc (F: 336P)

 
336P Technical Analysis
5
As on 10th May 2023 336P STOCK Price closed @ 0.46 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.81 & Strong Sell for SHORT-TERM with Stoploss of 1.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

336PSTOCK Price

Open 0.58 Change Price %
High 0.58 1 Day -0.13 -22.03
Low 0.46 1 Week -0.15 -24.59
Close 0.46 1 Month -0.19 -29.23
Volume N/A 1 Year -0.80 -63.49
52 Week High 1.26 | 52 Week Low 0.25
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
336P
Daily Charts
336P
Intraday Charts
Whats New @
Bazaartrend
336P
Free Analysis
 
336P Important Levels Intraday
RESISTANCE0.69
RESISTANCE0.62
RESISTANCE0.57
RESISTANCE0.53
SUPPORT0.39
SUPPORT0.35
SUPPORT0.30
SUPPORT0.23
 
336P Forecast December 2024
4th UP Forecast1.17
3rd UP Forecast0.94
2nd UP Forecast0.8
1st UP Forecast0.66
1st DOWN Forecast0.26
2nd DOWN Forecast0.12
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.25
 
336P Weekly Forecast
4th UP Forecast0.61
3rd UP Forecast0.56
2nd UP Forecast0.53
1st UP Forecast0.50
1st DOWN Forecast0.42
2nd DOWN Forecast0.39
3rd DOWN Forecast0.36
4th DOWN Forecast0.31
 
336P Forecast2024
4th UP Forecast2.37
3rd UP Forecast1.76
2nd UP Forecast1.38
1st UP Forecast1
1st DOWN Forecast-0.08
2nd DOWN Forecast-0.46
3rd DOWN Forecast-0.84
4th DOWN Forecast-1.45
 
 
336P Other Details
Segment EQ
Market Capital 94474104.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
336P Address
336P
 
336P Latest News
 
Your Comments and Response on Hepion Pharmaceuticals Inc
 
336P Business Profile
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service